Gain Therapeutics Bolsters Management Team with the

BETHESDA, Md., April 08, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology...

Related Keywords

Switzerland ,Swiss ,Elio Ambrosio ,Matthias Alder ,Nic Johnson ,Exchange Commission On ,Company Annual Report On Form ,Silverstein Foundation For Parkinson ,European Union Horizon ,Michaelj Fox Foundation For Parkinson Research ,Lazard ,Linkedin ,Gain Therapeutics Inc ,Nasdaq ,Gruntal Co ,Swiss Innovation Agency ,Exchange Commission ,Fordham University ,Merck Co ,Gene Mack ,Gain Therapeutics ,Equity Incentive Plan ,Nasdaq Listing Rule ,Initial Vesting Date ,Silverstein Foundation ,Swiss Innovation ,Site Directed Enzyme Enhancement Therapy ,Private Securities Litigation Reform Act ,Annual Report ,Nasdaq Ganx ,Nc ,Spanx ,